Eversheds advises Recordati Spa on the acquisition of shares in Opalia Pharma
Eversheds has advised Recordati Spa, an Italian group of pharmaceutical laboratories, on the acquisition of 67 per cent of shares in Tunisian pharmaceutical company Opalia Pharma.
Milan-based Recordati was advised by Eversheds Paris in collaboration with Eversheds El Heni in Tunisia, with partners Boris Martor, Farès Koussay El Heni, Raouf Mohamed El Heni and Dan Roskis working closely with associates Jawad Fassi-Fehri and Imène Boukadoum.
Further counsel was provided by Anna Buscall of Arnold & Porter.
News from Eversheds
News from The Lawyer
Briefings from Eversheds
The notion of ‘gross negligence’ is an important matter for customers and institutions alike and has been reviewed by the High Court and Supreme Court in deciding a recent case.
This report includes an analysis of the results of Eversheds survey on the Employment Tribunal process, which is based on 180 responses.
Analysis from The Lawyer
‘Exotic’ investors and opportunities for legal work beyond M&A feature in The Lawyer’s high-level roundtable debate on south-east Europe
Could Slater & Gordon achieve its stated aim of becoming a top consumer brand by acquiring Pannone?